Feyyaz Özdemir

835 total citations
76 papers, 587 citations indexed

About

Feyyaz Özdemir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Feyyaz Özdemir has authored 76 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Feyyaz Özdemir's work include Gastric Cancer Management and Outcomes (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Feyyaz Özdemir is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Feyyaz Özdemir collaborates with scholars based in Türkiye, United States and Switzerland. Feyyaz Özdemir's co-authors include Halil Kavgacı, Fazıl Aydin, Melek Yavuz, Kübra Kaynar, Ahmet Menteşe, Faruk Aydın, Asım Örem, Ercüment Ovalı, Şükrü Ulusoy and Ümit Çobanoğlu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Feyyaz Özdemir

72 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feyyaz Özdemir Türkiye 13 217 118 97 95 75 76 587
Halil Kavgacı Türkiye 14 174 0.8× 132 1.1× 106 1.1× 96 1.0× 68 0.9× 55 623
Salim Başol Tekin Türkiye 14 297 1.4× 71 0.6× 131 1.4× 114 1.2× 53 0.7× 50 627
Xiaonan Zheng China 15 179 0.8× 134 1.1× 212 2.2× 127 1.3× 55 0.7× 66 733
Theodotis Papageorgiou Greece 15 255 1.2× 220 1.9× 89 0.9× 194 2.0× 56 0.7× 52 955
Jean-Christophe Boyer France 14 219 1.0× 136 1.2× 82 0.8× 168 1.8× 67 0.9× 35 634
Hüseyin Engin Türkiye 13 139 0.6× 138 1.2× 108 1.1× 61 0.6× 39 0.5× 50 453
Mahvish Muzaffar United States 13 348 1.6× 97 0.8× 143 1.5× 88 0.9× 57 0.8× 66 607
Wojciech Błogowski Poland 16 183 0.8× 206 1.7× 76 0.8× 141 1.5× 33 0.4× 42 655
T. Malachi Israel 15 165 0.8× 203 1.7× 109 1.1× 98 1.0× 35 0.5× 33 739
Ming‐Shen Dai Taiwan 17 278 1.3× 206 1.7× 171 1.8× 57 0.6× 66 0.9× 71 771

Countries citing papers authored by Feyyaz Özdemir

Since Specialization
Citations

This map shows the geographic impact of Feyyaz Özdemir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feyyaz Özdemir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feyyaz Özdemir more than expected).

Fields of papers citing papers by Feyyaz Özdemir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feyyaz Özdemir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feyyaz Özdemir. The network helps show where Feyyaz Özdemir may publish in the future.

Co-authorship network of co-authors of Feyyaz Özdemir

This figure shows the co-authorship network connecting the top 25 collaborators of Feyyaz Özdemir. A scholar is included among the top collaborators of Feyyaz Özdemir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feyyaz Özdemir. Feyyaz Özdemir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özdemir, Feyyaz, et al.. (2022). Hearing Loss After the First Low Dose Administration of Cisplatin. Journal of College of Physicians And Surgeons Pakistan. 32(9). 1216–1218. 1 indexed citations
2.
Özdemir, Feyyaz, et al.. (2021). Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancer. Anti-Cancer Drugs. 32(8). 882–885. 2 indexed citations
3.
Yalçın, Şuayib, Ramazan Yıldız, Faysal Dane, et al.. (2018). A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study. OncoTargets and Therapy. Volume 11. 1223–1228. 2 indexed citations
4.
Kavgacı, Halil, et al.. (2018). The effects of environmental and dietary factors on the development of gastric cancer.. PubMed. 19(4). 1076–82. 9 indexed citations
5.
Koçoğlu, Hakan, Halil Kavgacı, Meral Günaldı, et al.. (2018). The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis. Journal of Cancer Research and Therapeutics. 14(10). 583–583. 13 indexed citations
6.
Özdemir, Feyyaz, et al.. (2016). Karbonhidratlar ve Kanser. 9(3). 1–6. 1 indexed citations
7.
Turhal, Nazım Serdar, et al.. (2016). Changes in lifestyle upon diagnosis of cancer or other chronic illnesses: A Turkish Oncology Group study. Journal of Health Psychology. 23(4). 561–566.
8.
Özdemir, Feyyaz, et al.. (2014). Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey. Balkan Medical Journal. 31(2). 126–131. 2 indexed citations
9.
Kurt, Ender, Erdem Çubukçu, Bülent Karabulut, et al.. (2013). A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.. PubMed. 18(1). 147–53. 3 indexed citations
10.
Ürün, Yüksel, Güngör Utkan, Şuayib Yalçın, et al.. (2012). Lack of Any Relationship between ABO and Rh Blood Groups and Clinicopathological Features in Patients with Gastrointestinal Stromal Tumors: Turkish Oncology Group. Asian Pacific Journal of Cancer Prevention. 13(8). 4129–4131. 8 indexed citations
11.
Reis, Abdülkadir, et al.. (2011). Undifferentiated carcinoma of the epididymis.. PubMed. 50(3). 415–8. 1 indexed citations
12.
Saip, Pınar, Serkan Keskın, Güzin Demirağ, et al.. (2011). TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA.. 7(2). 109–117. 2 indexed citations
13.
Durmuş, İsmet, et al.. (2011). Bolus fluorouracil induced syncope and pulseless ventricular tachycardia: a case report.. PubMed. 15(1). 93–5. 5 indexed citations
14.
Aydın, Faruk, et al.. (2011). Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer.. PubMed. 112(9). 521–3. 8 indexed citations
15.
Özdemir, Feyyaz, et al.. (2010). Primary t-cell lymphoma of the breast: A case report. SHILAP Revista de lepidopterología. 6(3). 129–131.
16.
Kaynar, Kübra, et al.. (2007). Amikacin-Induced Nephropathy: Is There Any Protective Way?. Renal Failure. 29(1). 23–27. 27 indexed citations
17.
Özdemir, Feyyaz, Ercüment Ovalı, Fazıl Aydin, et al.. (2004). The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells.. PubMed. 23(1). 93–5. 3 indexed citations
18.
Kartı, S. Sami, Ercüment Ovalı, Mustafa Yılmaz, et al.. (2004). Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin.. PubMed. 50(54). 1864–6. 12 indexed citations
19.
Kavgacı, Halil, et al.. (2004). Carcinoma Erysipelatoides Resulting from Gastric Adenocarcinoma: An Unusual Clinical Presentation. Medical Principles and Practice. 14(1). 61–63. 8 indexed citations
20.
Aydin, Fazıl, et al.. (2002). Correlation of Serum IL-2, IL-6 and IL-10 Levels With International Prognostic Index in Patients With Aggressive Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology. 25(6). 570–572. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026